Epsiprantel is a veterinary anthelmintic Active Pharmaceutical Ingredient (API) used to treat tapeworm infections (e.g., Echinococcus granulosus) in dogs and cats. It functions by causing paralysis in the parasite, allowing the animal’s body to pass it naturally. It is grouped under the following drug class(es): Anthelmintics. Its therapeutic use is listed as antiparasitics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Cestex and Epsiprantelum. Its PubChem CID is 72026.
Epsiprantel
| CAS No | 98123-83-2 |
|---|---|
| Molecular Formula | C20H26N2O2 |
| Molecular Weight | 326.4 g/mol |
| Synonyms | 2-(cyclohexanecarbonyl)-1,3,6,7,8,12b-hexahydropyrazino[2,1-a][2]benzazepin-4-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
, Echinococcus granulosus) in dogs and cats. It functions by causing paralysis in the parasite, allowing the animal's body to pass it naturally. It is grouped under the following drug class(es): Anthelmintics.
The listed CAS number is 98123-83-2.
The listed molecular formula is C20H26N2O2.
The listed molecular weight is 326.4 g/mol.
2-(cyclohexanecarbonyl)-1,3,6,7,8,12b-hexahydropyrazino[2,1-a][2]benzazepin-4-one.
The source lists Cestex and Epsiprantelum.